AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Jalra-M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

USV Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Jalra-M 50mg/1000mg Tablet

Combiflex-DM 50mg/1000mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflex-DM may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved through consistent medication use, coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Ingestion with meals minimizes gastrointestinal distress. For maximum benefit, adhere to a consistent daily dosing schedule; discontinuation should only occur under physician guidance. Effective blood sugar regulation helps prevent future complications. Maintaining the prescribed diet and exercise regimen is crucial; lifestyle choices significantly impact diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; patients should be aware of its symptoms and management. This medication is not universally suitable. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require physician consultation. Interaction with other medications is possible; disclose all current medications to ensure treatment safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Primary Ingredients of Jalra-M 50mg/1000mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Jalra-M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Jalra-M 50mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Jalra-M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Jalra-M 50mg/1000mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Jalra-M 50mg/1000mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Jalra-M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Jalra-M 50mg/1000mg Tablet works:

A single Jalra-M tablet (50mg/1000mg) combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Jalra-M 50mg/1000mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jalra-M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Jalra-M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Jalra-M 50mg/1000mg tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised.

LiverLiverUNSAFE

Individuals with liver impairment should likely abstain from Jalra-M 50mg/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Jalra-M 50mg/1000mg Tablet :

Should you forget a Jalra-M 50mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jalra-M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Jalra-M 50mg/1000mg Tablet

Jalra-M 50mg/1000mg tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate low blood sugar. These symptoms are more prominent if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is therefore crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Jalra-M 50mg/1000mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Patients with allergies to Jalra-M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Jalra-M 50mg/1000mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Lactic acidosis, a serious medical emergency (also called MALA, or Metformin-associated lactic acidosis), is a potential, though rare, side effect of Jalra-M 50mg/1000mg Tablets. This condition results from excessive lactic acid in the bloodstream and is reason to avoid this medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Jalra-M 50mg/1000mg Tablets and seek immediate medical attention.
Prolonged use of Jalra-M 50mg/1000mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Jalra-M 50mg/1000mg tablets are safe when taken as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (with insulin or sulphonylurea use) may occur. Report any persistent issues to your doctor.
Jalra-M 50mg/1000mg Table...
368
MRP 426
13% off